AAS is not a concern for LEO or much for the feds, but the glp1's are already an industry in the billions. UGL have gone mainstream due to Reddit and FB Karen's. It just takes a couple of FB Karen's to attribute some disease or condition to UGL semaglutide or tirzepatide for it to make national news. The Karens are posting pictures of packages often including shipping information and details about ordering, payments and questions about reshipping. These peptides will bring a ton of scrutiny to UGL providers. Multiple Chinese vendors are now offering peptides US domestic (along with their AAS products) which are certainly at risk due to the new attention. Big pharma has HUGE influence in D.C.
See prohormone ban in the mid 2000s, the ephedrine ban also. Yes, it has happened before when the media puts too much attention on something then eventually congress overreacts.
Some people understand.
GLP-1s are going to be a trillion dollar business in no time, and some don't understand the influence of pharma in DC. Sales of items like this don't happen in China without being allowed, and things can quickly become not allowed for many reasons.
Publicity about grey market activities and laughing in the face of FDA, big pharma, and government never ends well.
